
Why Is State Street SPDR S&P Biotech ETF (AMEX: XBI) Stock Up Today?
Live update on XBI's movement on the AMEX, with key data on price change, volume, technical indicators, sector trends, and analyst sentiment.
XBI is Down -1.15% today
You might want to check out Why is XBI Down Today?
State Street SPDR S&P Biotech ETF (AMEX: XBI) Update
State Street SPDR S&P Biotech ETF (AMEX: XBI) Summary
State Street SPDR S&P Biotech ETF (AMEX: XBI) is trading down -1.15% at $150.48, reflecting a negative shift in investor sentiment today. The stock opened at $152.78 and has moved between $149.91 and $153.28 so far.
Trading volume is 7385565, which is 18% below its average, and the price action suggests selling interest.
Technically, XBI on the AMEX is trading above its 50-day moving average of $143.30 and above its 200-day moving average of $127.69, indicating short-term and long-term strength.
Meyka's AI assigns XBI a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of +4.76% in 1 month ($157.65), -10.53% in 1 year ($134.63), and +34.99% in 5 years ($203.14).
See full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement on the AMEX.
Stay informed and make better investment decisions.
XBI (AMEX) Technical Signals
Trading over 50-day moving average ($143.30)
Trading over 200-day moving average ($127.69)
Price Forecast
1 Month
$157.65
1 Year
$134.63
3 Years
$168.87
5 Years
$203.14
Is this change significant?
5-Day:+0.64%
1-Month:+0.55%
3-Month:+12.94%
What's next?
Next earnings date: 7/30/2025